Clinical TrialsSearch results
Number of results: 286
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Study of imatinib monotherapy and combination of imatinib with IFN or cytarabine ocfosfate for chronic-phase CML (JALSG CML202 Study)
- Previously untreated chronic-phase chronic myelogenous leukemia
- Japan Adult Leukemia Study Group
- 2005-09-10
Other
- Study of High dose Toremifene for metastatic breast cancer after failure of adjuvant therapy of Aromatase Inhibitor
- First line therapy for recurrence or metastatic postmenopausal breast cancer
- Nagoya University of School of Medicine Breast and Endocrine Surgery
- 2006-10-01
Other
- study of Helicobacter pylori Eradication after endoscopic resection of early gastric cancer
- early stage of gastric cancer
- Japan Gast Study Group
- 2008-05-31
Other
- Study of Docetaxle and trastuzumab as preoperative chemotherapy for advanced-stage breast cancer with HER2 over expression
- Breast Cancer
- Toukai Breast Cancer Clinical Reserch Group
- 2005-09-12
Other
- Study of Circulating Progenitor Cells and Myocardial Infarction
- Ischemic heart disease
- Nagoya University
- 2009-04-01
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Other
- Secondary Prevention of Cerebral Infarction Epidemiological Study on Cerebral Microbleeds
- cerebral infaction
- SCIENCE Study Protocol Comittee
- 2008-07-02
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Safety and Immunogenicity of Cholesterol-Bearing Hydrophobized Pullulan HER2 Protein 146 (CHP-HER2) and NY-ESO-1 Protein (CHP-NY-ESO-1) in Combination With OK-432 in HER2- and/or NY-ESO-1-Expressing Cancers
- Esophageal Cancer, Lung Cancer, Stomach Cancer, Breast Cancer, Ovarian Cancer
- Mie University Graduate School of Medicine, Kitano Hospital
- 2008-03-16